Blood Work Education
THYROID FUNCTION
Understanding your thyroid panel -- TSH, Free T4, Free T3, and TPO Antibodies explained with clinical context.
Medically reviewed by Missy Zammichieli, DNP, APRN, FNP-BC ยท Updated March 2, 2026
THE BOTTOM LINE
- • TSH is your best early-warning marker. It catches thyroid problems before you feel them.
- • A full panel tells a more complete story than TSH alone -- it shows production, conversion, and whether your immune system is attacking the gland.
- • Thyroid dysfunction is common and often missed. Over 12% of Americans will develop a thyroid condition; up to 60% won't know it.
- • If you take biotin, stop it at least 48-72 hours before your blood draw. It can throw off your results and make it look like you have a thyroid problem when you don't.
INTRODUCTION
Your thyroid is a small gland at the base of your neck that acts as the body's metabolic thermostat. It produces hormones that regulate metabolic rate, body temperature, heart rate, energy, weight, and mood. Nearly every cell has thyroid hormone receptors, which is why thyroid problems cause such wide-ranging symptoms -- fatigue, weight changes, hair loss, constipation, depression, and more.
Women are five to eight times more likely than men to be affected. A TSH test alone catches most disorders, but a full panel shows whether the thyroid is producing adequately, whether the body is converting hormones well, and whether autoimmune activity may be damaging the gland. For strategies for thyroid optimization — including why “normal” ranges may not be optimal — see our companion guide.
YOUR BIOMARKERS EXPLAINED
TSH (Thyroid Stimulating Hormone)
What it measures: TSH is produced by your pituitary gland to tell the thyroid to make hormones. It's the most sensitive single marker for thyroid dysfunction.
How it works: Your brain monitors thyroid hormone levels. When levels drop, the pituitary sends more TSH to tell the thyroid to ramp up. When levels are adequate, TSH backs off -- like a thermostat cranking up the heat when the room gets cold.
TSH moves opposite to thyroid hormones: a struggling thyroid produces less, so TSH rises; an overactive thyroid produces too much, so TSH drops. TSH is extremely sensitive -- even a small change in thyroid hormone causes a large swing in TSH, making it the best early warning marker.
Reference ranges:
- • Standard range: 0.45 -- 4.12 mIU/L
- • Studies of screened healthy individuals suggest the true upper limit may be closer to 2.5 mIU/L
- • Pregnancy: Trimester-specific ranges apply
What can cause abnormalities: Primary thyroid disease (most common), pituitary disorders (rare), acute illness, medications (dopamine, glucocorticoids, biotin), and time of day -- TSH varies up to 50% across the day, peaking overnight and lowest in late afternoon.
Free T4 (Free Thyroxine)
What it measures: The usable fraction of thyroxine in your blood. T4 is the thyroid's main output -- the storage form, with a half-life of about a week.
Why "free" matters: Over 99% of T4 is bound to carrier proteins and inactive. Only the free fraction enters cells and does work. Pregnancy, estrogen therapy, and liver disease can change total T4 without affecting the active pool, so we measure Free T4 instead.
Its role: T4 converts into the more active T3 in your liver, kidneys, and muscles. Only about 20% of circulating T3 comes directly from the thyroid -- the rest is made from T4.
Reference ranges: 0.8 -- 1.8 ng/dL (exact ranges vary by lab)
What can cause abnormalities: Primary thyroid disease, central hypothyroidism (low Free T4 with inappropriately normal TSH), medications (amiodarone, heparin), acute illness, and biotin interference.
Free T3 (Free Triiodothyronine)
What it measures: The usable fraction of T3, the most metabolically active thyroid hormone. T3 is three to five times more potent than T4 but shorter-lived (half-life of about one day).
Why it's on the panel: TSH and Free T4 handle most diagnoses, but Free T3 adds value when T3 rises before T4 in early hyperthyroidism, when conversion from T4 to T3 may be impaired, or when illness is suppressing T3 as its first effect.
Reference ranges: 2.3 -- 4.2 pg/mL (ranges vary by lab)
What can cause abnormalities: Thyroid disease, poor conversion from selenium deficiency or caloric restriction, acute illness, and medications including amiodarone and propranolol.
TPO Antibodies (Thyroid Peroxidase Antibodies)
What it measures: Antibodies your immune system makes against an enzyme the thyroid needs to produce hormones. When the immune system attacks this enzyme, it can gradually damage the gland.
What positive antibodies mean: TPO antibodies are the hallmark of autoimmune thyroid disease, most commonly Hashimoto's -- the leading cause of hypothyroidism. About 11% of Americans have detectable TPO antibodies (17% of women, 9% of men).
Risk implications: Elevated TPO with normal thyroid levels means your gland is compensating for now. A 20-year study found women with positive antibodies had a 2-4% annual risk of developing hypothyroidism, higher if TSH was also trending up.
Reference ranges: Less than 35 IU/mL (threshold varies by lab). Low-level positivity can occur without clinical disease.
What can cause positivity: Hashimoto's thyroiditis, Graves' disease, other autoimmune conditions (type 1 diabetes, rheumatoid arthritis), family history, and postpartum thyroiditis.
HOW THESE MARKERS TELL A STORY TOGETHER
The real value of a thyroid panel is in the pattern, not any single number.
Underactive thyroid (hypothyroidism): High TSH + low Free T4. The thyroid is underproducing. Positive TPO antibodies point to Hashimoto's as the cause.
Mildly underactive thyroid (subclinical hypothyroidism): Slightly elevated TSH + normal Free T4. Common (4-8% of people). Whether it needs treatment depends on TSH level, symptoms, and antibody status.
Overactive thyroid (hyperthyroidism): Very low TSH + elevated Free T4 and/or Free T3.
Mildly overactive thyroid (subclinical hyperthyroidism): Very low TSH + normal Free T4 and Free T3. Your thyroid may be running slightly hot, which over time has been linked to irregular heart rhythms and weaker bones.
Central hypothyroidism: Low Free T4 + inappropriately normal or low TSH. A rare pattern indicating a pituitary problem rather than a thyroid problem.
Normal levels with positive antibodies: TSH, T4, and T3 are fine, but TPO antibodies are elevated. The gland is under autoimmune attack but still functioning. Increased risk for future hypothyroidism -- periodic monitoring is warranted.
The spectrum: Thyroid dysfunction isn't binary. Subclinical disease progresses to overt disease at roughly 2-5% per year -- faster with higher TSH and positive antibodies.
WHAT AFFECTS THESE RESULTS
Biotin Supplements
The FDA has warned that biotin can interfere with thyroid tests, causing falsely low TSH and falsely high Free T4/T3 -- mimicking an overactive thyroid. Stop biotin at least 48-72 hours before blood work.
Time of Day
TSH peaks overnight and is lowest in late afternoon, varying up to 50%. Morning draws capture higher values.
Acute Illness
Being sick can temporarily alter results -- typically lowering T3 first. Resolves as you recover.
Medications
Amiodarone can cause hypo- or hyperthyroidism. Lithium inhibits thyroid hormone release. Glucocorticoids suppress TSH. Estrogen and oral contraceptives affect total but not free hormone levels.
Iodine
Excess iodine from supplements, seaweed, or contrast dye can temporarily suppress thyroid function or trigger hyperthyroidism in susceptible individuals.
Pregnancy
hCG can lower TSH in the first trimester, which is why trimester-specific ranges exist.
Stress and Caloric Restriction
Both reduce T4-to-T3 conversion as an energy-conservation mechanism, lowering Free T3.
COMMON QUESTIONS
"My TSH is normal but I still have symptoms."
A normal TSH doesn't guarantee optimal thyroid function. Free T3 may be low from poor conversion, TPO antibodies may signal early autoimmune activity before TSH shifts, or the symptoms may have a non-thyroid cause entirely. Your personal TSH "sweet spot" may also be narrower than the population reference range -- a result that's technically normal could still represent a shift from your baseline.
"What do positive antibodies mean if my levels are normal?"
Your immune system is targeting the thyroid, but the gland is still keeping up. Long-term studies show increased risk of future hypothyroidism, but it's not a certainty -- some people maintain normal function indefinitely. It supports periodic monitoring so you catch any change early.
"How often should thyroid be rechecked?"
Every 6-12 months for subclinical hypothyroidism with positive antibodies. Periodic testing is also recommended with risk factors like family history of autoimmune disease, prior radiation, or thyroid-affecting medications. A first-time elevated TSH should generally be repeated in 6-8 weeks with Free T4 and TPO antibodies to distinguish a blip from a real trend.
"Does stress affect thyroid function?"
Acute illness reduces T4-to-T3 conversion, often lowering Free T3. Chronic psychological stress has a less defined impact. Caloric restriction and overtraining are more consistently associated with reduced T3 as an energy-conservation adaptation.
References
- 1. Brent GA. Mechanisms of thyroid hormone action. Journal of Clinical Investigation. 2012;122(9):3035-3043.
- 2. Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. The Lancet. 2017;390(10101):1550-1562.
- 3. American Thyroid Association. General information/press room: prevalence and impact of thyroid disease.
- 4. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. Journal of Clinical Endocrinology & Metabolism. 2002;87(2):489-499.
- 5. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: AACE and ATA. Endocrine Practice. 2012;18(6):988-1028.
- 6. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: ATA Task Force. Thyroid. 2014;24(12):1670-1751.
- 7. Spencer CA, LoPresti JS, Patel A, et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. Journal of Clinical Endocrinology & Metabolism. 1990;70(2):453-460.
- 8. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003;13(1):3-126.
- 9. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the ATA for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017;27(3):315-389.
- 10. Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. The Lancet Diabetes & Endocrinology. 2015;3(10):816-825.
- 11. U.S. Food and Drug Administration. FDA Safety Communication: The FDA warns that biotin may interfere with lab tests. November 28, 2017; updated 2019.
- 12. Brabant G, Prank K, Ranft U, et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. Journal of Clinical Endocrinology & Metabolism. 1990;70(2):403-409.
- 13. Mendoza A, Hollenberg AN. New insights into thyroid hormone action. Pharmacology & Therapeutics. 2017;173:135-145.
- 14. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews. 2002;23(1):38-89.
- 15. Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20(7):763-770.
- 16. de Vries EM, Fliers E, Boelen A. The molecular basis of the non-thyroidal illness syndrome. Journal of Endocrinology. 2015;225(3):R67-R81.
- 17. Vanderpump MPJ. The epidemiology of thyroid disease. British Medical Bulletin. 2011;99(1):39-51.
- 18. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology. 1995;43(1):55-68.
- 19. Weetman AP. Diseases associated with thyroid autoimmunity: explanations for the expanding spectrum. Clinical Endocrinology. 2011;74(4):411-418.
- 20. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocrine Reviews. 2008;29(1):76-131.